Why is AcelRx Pharmaceuticals Inc. (ACRX) down -16.29% from the day 1 this year?

At the end of the latest market close, AcelRx Pharmaceuticals Inc. (ACRX) was valued at $1.69. In that particular session, Stock kicked-off at the price of $1.71 while reaching the peak value of $1.90 and lowest value recorded on the day was $1.68. The stock current value is $1.85.

Recently in News on September 29, 2020, AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA®. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it will host a virtual Key Opinion Leader (KOL) event on the perioperative use of DSUVIA, on Wednesday, October 7, 2020 at 12 pm ET (9 am PT). You can read further details here


My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<

Sponsored


AcelRx Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1400 on 01/02/20, with the lowest value was $0.7014 for the same time period, recorded on 03/23/20.

AcelRx Pharmaceuticals Inc. (ACRX) full year performance was -16.29%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, AcelRx Pharmaceuticals Inc. shares are logging -26.00% during the 52-week period from high price, and 163.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.70 and $2.50.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1529201 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the AcelRx Pharmaceuticals Inc. (ACRX) recorded performance in the market was -12.32%, having the revenues showcasing 56.78% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 148.48M, as it employees total of 54 workers.

Market experts do have their say about AcelRx Pharmaceuticals Inc. (ACRX)

During the last month, 0 analysts gave the AcelRx Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3299, with a change in the price was noted +0.5300. In a similar fashion, AcelRx Pharmaceuticals Inc. posted a movement of +40.15% for the period of last 100 days, recording 1,514,823 in trading volumes.

Technical breakdown of AcelRx Pharmaceuticals Inc. (ACRX)

Raw Stochastic average of AcelRx Pharmaceuticals Inc. in the period of last 50 days is set at 74.07%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 70.59%. In the last 20 days, the company’s Stochastic %K was 59.61% and its Stochastic %D was recorded 59.85%.

Bearing in mind the latest performance of AcelRx Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -12.32%. Additionally, trading for the stock in the period of the last six months notably improved by 28.47%, alongside a downfall of -16.29% for the period of the last 12 months. The shares increased approximately by 10.12% in the 7-day charts and went down by 20.92% in the period of the last 30 days. Common stock shares were driven by 56.78% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the Investchronicle.com pre-market morning brief 100% free